Clinical Trial Update: A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome [NA]

View source ↗

Summary

This entry describes a feasibility study to evaluate the safety and potential benefit of the Eclipse XL1 System for distraction enterogenesis in adults and chil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Eclipse XL1 System

Snippet

Sponsor: Eclipse Regenesis, Inc. | Conditions: Short Bowel Syndrome | NA | Status: RECRUITING